COCA-COLA EUROPACIFIC PARTNERS Plc current report, Q4 FY2021

Business Context and Reporting Period

Coca-Cola Europacific Partners Plc (CCEP) issued a Form 6-K trading update for the third quarter ended October 1, 2021. The report covers the period following the acquisition of Coca-Cola Amatil Limited (API), which was completed on May 10, 2021. The update includes financial performance, operational highlights, and a declaration of the full-year 2021 dividend.

Key Financial Metrics

Revenue and Volume

  • Q3 2021 Reported Revenue: €3,949 million (up 24.0% vs. Q3 2020).
  • Q3 2021 Pro Forma Comparable Revenue: €3,949 million (up 2.5% vs. Q3 2020).
  • Q3 2021 Pro Forma Comparable Volume: 796 million unit cases (down 1.5% vs. Q3 2020).
  • Q3 2021 Revenue per Unit Case: €4.88 (up 2.0% vs. Q3 2020).
  • YTD 2021 Reported Revenue: €9,867 million (up 23.0% vs. YTD 2020).
  • YTD 2021 Pro Forma Comparable Revenue: €10,923 million (up 9.0% vs. YTD 2020).

Profitability and Dividends

  • Dividend Declaration: Full-year interim dividend of €1.40 per share, representing a 64.5% increase vs. 2020 and a 13.0% increase vs. 2019.
  • Dividend Payout Ratio: Maintained at approximately 50% of comparable profit after tax.
  • Operating Profit & EPS: Specific Q3 operating profit and EPS figures are not provided in this text; however, full-year guidance has been raised (see below).

Liquidity and Debt

The filing text does not provide specific values for cash flow, debt levels, or liquidity ratios for the reporting period.

Material Changes vs. Prior Period

  • Revenue Growth: Reported revenue growth of 24.0% in Q3 was driven significantly by the inclusion of API. On a pro forma comparable basis, revenue grew 2.5%, while FX-neutral revenue grew 0.5%.
  • Volume Trends: Pro forma comparable volume declined 1.5% in Q3, impacted by adverse weather in Europe and renewed COVID-19 restrictions in the API region (Australia, New Zealand, Pacific Islands). This compares to a 5.5% decline vs. 2019 levels.
  • Channel Performance: Away from Home (AFH) volumes grew 4.0% due to HoReCa recovery in Europe, while Home channel volumes declined 5.0%.
  • Geographic Variance: Great Britain and Iberia showed revenue growth, while France, Germany, and Northern Europe experienced declines primarily due to weather and restrictions.

Guidance, Outlook, and Management Commentary

Updated FY21 Guidance (Comparable Basis)

  • Revenue: Comparable growth of 29-30% (raised from 26-28%).
  • Operating Profit: Comparable growth of 46-49% (raised from 40-44%).
  • EPS: Comparable growth of 54-57% (new guidance).
  • Effective Tax Rate: Approximately 20% (unchanged).

FY22 Outlook (Pro Forma Comparable & FX-Neutral)

  • Cost of Sales per Unit Case: Pro forma comparable growth of 4-5% (new guidance).

Management Commentary

CEO Damian Gammell highlighted solid top-line growth and value share gains, noting the successful integration of API. Management expressed confidence in mitigating inflationary pressures and supply chain challenges through pricing, mix, and procurement initiatives. The company is raising guidance due to the lifting of restrictions in API and continued recovery in Europe.

Risks and Contingencies

  • COVID-19: Ongoing pandemic developments and government restrictions remain a primary risk.
  • Integration: Risks associated with the successful integration of API, including potential disruption and cost overruns.
  • External Factors: Inflationary pressures, global supply chain challenges, and adverse weather conditions.

Key Facts for Investor Verification

  • Verify the reconciliation of reported revenue to pro forma comparable revenue to understand the full impact of the API acquisition.
  • Confirm the specific impact of inflation on cost of sales per unit case against the new FY22 guidance of 4-5% growth.
  • Monitor the execution of the API portfolio strategy, specifically the exit from beer and cider production and the sale of Feral craft beer.
  • Track the progress of sustainability commitments, including the transition to 100% recycled PET (rPET) in Germany and France.
  • Review the full-year 2021 preliminary results scheduled for release on February 16, 2022, to validate the raised guidance targets.